Technology Development for the Synthesis of S-Amlodipine Nicotinate Drug Substance

被引:0
|
作者
G. A. Kim
Zh. M. Kozlova
S. O. Pchelintsev
R. T. Savel’yanova
N. M. Berezina
I. I. Krasnyuk
机构
[1] Ministry of Public Health of the Russian Federation,All
[2] I. M. Sechenov First Moscow State Medical University,Russia Scientific Center for Safety Testing of Biologically Active Substances
[3] EcoChem-Innovations,undefined
来源
关键词
-amlodipine nicotinate; amlodipine optical isomers; nicotinic acid;
D O I
暂无
中图分类号
学科分类号
摘要
Technology for the synthesis of S-amlodipine nicotinate drug substance was developed based on an acceptable method of effective separation of the amlodipine optical isomers. A literature review suggested that the most promising methods employed 2-propanol (pure or with small additions of cosolvents) as the main solvent. However, experiments showed that the optimum solvent was DMSO. The proposed synthesis of S-amlodipine nicotinate drug substance was confirmed to be stable and reproducible. Standardization methods were developed.
引用
收藏
页码:761 / 763
页数:2
相关论文
共 50 条
  • [31] PHARMACOKINETICS AND BIOEQUIVALENCE OF TELMISARTAN/SAMLODIPINE COMBINATION TABLETS AND CO-ADMINISTRATION OF TELMISARTAN AND S-AMLODIPINE IN HEALTHY VOLUNTEERS.
    Seong, S.
    Kang, W.
    Ohk, B.
    Kim, B.
    Gwon, M. -R.
    Kim, H. -J.
    Lee, H.
    Yoon, Y. -R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S45 - S46
  • [32] Ambulatory blood pressure response to S-amlodipine in Korean adult patients with uncontrolled essential hypertension: A prospective, observational study
    Kim, Dong Kyun
    Ahn, Joon Ho
    Lee, Ki Hong
    Kang, Si-Hyuck
    Kim, Sung Soo
    Na, Jin Oh
    Park, Sang Don
    Ahn, Kye Taek
    Lee, Jung-Hee
    Jung, In Hyun
    Seo, Jongkwon
    Choi, Woong Gil
    JOURNAL OF CLINICAL HYPERTENSION, 2022, 24 (03): : 350 - 357
  • [33] Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers
    Oh, Minkyung
    Park, Sung-Eun
    Ghim, Jong-Lyul
    Choi, Young-Kyung
    Shim, Eon-Jeong
    Shin, Jae-Gook
    Kim, Eun-Young
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 3543 - 3550
  • [34] S-amlodipine improves endothelial dysfunction via the RANK/RANKL/OPG system by regulating microRNA-155 in hypertension
    Yang, Jining
    Si, Daoyuan
    Zhao, Yanan
    He, Chengyan
    Yang, Ping
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
  • [35] COMPARISON OF THE EFFICACY AND SAFETY OF FIXED-DOSE S-AMLODIPINE/TELMISARTAN AND TELMISARTAN IN HYPERTENSIVE PATIENTS INADEQUATELY CONTROLLED WITH TELMISARTAN
    Park, Chang
    Ahn, Tac
    Cho, Eun
    Kim, Won
    Kim, Hyung
    Rhu, Jac
    Kim, Chul
    Hyeon, Min
    Ha, Jong
    Pyeon, Wook
    Lee, Myeong
    JOURNAL OF HYPERTENSION, 2016, 34 : E293 - E294
  • [36] Formulation development of a transdermal drug delivery system for amlodipine base
    McDaid, DM
    Deasy, PB
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 133 (1-2) : 71 - 83
  • [37] Pharmacokinetic Interaction of Telmisartan With S-Amlodipine: An Open-Label, Two-Period Crossover Study in Healthy Korean Male Volunteers
    Noh, Yook-Hwan
    Lim, Hyeong-Seok
    Kim, Mi Jo
    Kim, Yo Han
    Choi, Hee Youn
    Sung, Hye Ryoung
    Jin, Seok-Joon
    Lim, Jonglae
    Bae, Kyun-Seop
    CLINICAL THERAPEUTICS, 2012, 34 (07) : 1625 - 1635
  • [38] RENAL SAFETY ASSESSMENT OF TELMISARTAN/S-AMLODIPINE SINGLE-PILL COMBINATION IN KOREAN HYPERTENSIVE PATIENTS: A MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDY
    Cho, Hyuk
    Han, Seung Seok
    Kim, Hee-Seok
    Min, Soung-Jun
    Kwon, Sung Uk
    Kim, Hyung-Kwan
    Hyon, Min-Su
    JOURNAL OF HYPERTENSION, 2024, 42
  • [39] Amorphous embedding of a lipophilic drug substance by Meltrex®-technology
    Rosenberg, J
    Degenhardt, M
    Breitenbach, J
    Mägerlein, M
    Berndl, G
    Hantke, T
    JOURNAL OF CONTROLLED RELEASE, 2003, 87 (1-3) : 264 - 267
  • [40] Evaluating drug substance– drug product interplay accelerates development
    Grass, Michael
    Pharmaceutical Technology, 2020, 2020 (04)